Modeling covalent-modifier drugs.
Awoonor-Williams E, Walsh AG, Rowley CN.
Biochim Biophys Acta Proteins Proteom. 2017 Nov;1865(11 Pt B):1664-1675. doi: 10.1016/j.bbapap.2017.05.009. Epub 2017 May 18.
Signalling mechanisms and cellular functions of SUMO.
Vertegaal ACO.
Nat Rev Mol Cell Biol. 2022 Nov;23(11):715-731. doi: 10.1038/s41580-022-00500-y. Epub 2022 Jun 24.
Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases.
Khalaf K, Tornese P, Cocco A, Albanese A.
Transl Neurodegener. 2022 Jun 4;11(1):33. doi: 10.1186/s40035-022-00307-z.
Introduction to Sumoylation.
Wilson VG.
Adv Exp Med Biol. 2017;963:1-12. doi: 10.1007/978-3-319-50044-7_1.
Chemical Metabolism of Xenobiotics by Gut Microbiota.
Nakov R, Velikova T.
Curr Drug Metab. 2020;21(4):260-269. doi: 10.2174/1389200221666200303113830.
Chemical journey of somatic cells to pluripotency.
Abbey D.
Cell Regen. 2022 Aug 3;11(1):27. doi: 10.1186/s13619-022-00126-7.
Biological, chemical, and biochemical strategies for modifying glycopeptide antibiotics.
Marschall E, Cryle MJ, Tailhades J.
J Biol Chem. 2019 Dec 6;294(49):18769-18783. doi: 10.1074/jbc.REV119.006349. Epub 2019 Oct 31.
Urm1: A Non-Canonical UBL.
Termathe M, Leidel SA.
Biomolecules. 2021 Jan 22;11(2):139. doi: 10.3390/biom11020139.
Elucidation of chemical modifier reactivity towards peptides and proteins and the analysis of specific fragmentation by matrix-assisted laser desorption/ionization collision-induced dissociation tandem mass spectrometry.
Rühl M, Kühn B, Roos J, Maier TJ, Steinhilber D, Karas M.
Rapid Commun Mass Spectrom. 2019 May;33 Suppl 1:40-49. doi: 10.1002/rcm.8223. Epub 2018 Aug 12.
SUMO proteases: from cellular functions to disease.
Claessens LA, Vertegaal ACO.
Trends Cell Biol. 2024 Nov;34(11):901-912. doi: 10.1016/j.tcb.2024.01.002. Epub 2024 Feb 6.
